drug · Product Intelligence

Pemetrexed
Pipeline Intelligence

Pemetrexed: 5 indexed trials, 3 sponsors; 0 linked Orange Book patents and 9 FDA-linked events where matched.

⚗

5Indexed trials

▦

3Sponsors

⌁

0Orange Book patent links

◎

9FDA-linked events

NCT02964013Merck Sharp & Dohme LLC · parkinsonsPHASE1

NCT03348904Incyte Corporation · parkinsonsPHASE3

NCT04220892Jose Carrillo · neuro_oncologyEARLY_PHASE1

NCT06788912Merck Sharp & Dohme LLC · parkinsonsPHASE2

NCT07252739Merck Sharp & Dohme LLC · parkinsonsPHASE2

Orange Book match found; no listed patent relation was retained for this product match.

FDA_APPROVALPEMETREXED DISODIUM · 2022-06-22

FDA_APPROVALPEMETREXED DITROMETHAMINE · 2022-06-10

FDA_APPROVALPEMETREXED DISODIUM · 2022-05-25

FDA_APPROVALPEMETREXED · 2020-08-21

FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.

PemetrexedPipeline Intelligence